FASEB J. Cell Migration Consortium
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Levy, G. N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Levy, G. N.

The FASEB Journal, Vol 11, 234-247, Copyright © 1997 by The Federation of American Societies for Experimental Biology

REVIEWS

Prostaglandin H synthases, nonsteroidal anti-inflammatory drugs, and colon cancer

GN Levy
Department of Pharmacology, University of Michigan, Ann Arbor 48109- 0632, USA.

Members of the structurally diverse class of drugs known as nonsteroidal anti-inflammatory drugs (NSAIDs) have the ability to prevent or reduce the occurrence of colorectal, certain other gastrointestinal, and perhaps other cancers. The anticarcinogenic property of NSAIDs has been shown in epidemiological studies with humans and in experimental carcinogenesis studies with animals. In addition, clinical studies of the human disease familial adenomatous polyposis have demonstrated the efficacy of NSAIDs in mediating regression of colorectal adenomas. The mechanism of the anticarcinogenic effect of these drugs is not known, but most hypotheses have involved the common property of the NSAIDs to inhibit prostaglandin synthase (PHS) enzymes and thereby cause a subsequent reduction in levels of prostaglandins (PG) in tissue. Recent reports have questioned the role of PHS inhibition in the anticarcinogenic activity of NSAIDs by showing that some NSAID-related compounds that are not PHS inhibitors can induce the same anticarcinogenic changes in cell cycle and apoptotic response as the PHS inhibitors. In this review we will examine the evidence that NSAIDs are anticarcinogenic, the evidence supporting PHS as the target of NSAIDs, and the evidence for and against inhibition of PG synthesis as the mechanism of cancer prevention by NSAIDs.


This article has been cited by other articles:


Home page
 J. Nutr.Home page
H. J. Cho, M. R. Seon, Y. M. Lee, J. Kim, J.-K. Kim, S. G. Kim, and J. H. Y. Park
3,3'-Diindolylmethane Suppresses the Inflammatory Response to Lipopolysaccharide in Murine Macrophages
J. Nutr., January 1, 2008; 138(1): 17 - 23.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Clin. Nutr.Home page
R J. Barnard
Prostate cancer prevention by nutritional means to alleviate metabolic syndrome
Am. J. Clinical Nutrition, September 1, 2007; 86(3): 889S - 893S.
[Abstract] [Full Text] [PDF]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
W.-G. Deng, A. J. Montero, and K. K. Wu
Interferon-{gamma} Suppresses Cyclooxygenase-2 Promoter Activity by Inhibiting C-Jun and C/EBP{beta} Binding
Arterioscler. Thromb. Vasc. Biol., August 1, 2007; 27(8): 1752 - 1759.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
A. M. Silva, D. Wang, A. A. Komar, B. A. Castilho, and B. R. G. Williams
Salicylates Trigger Protein Synthesis Inhibition in a Protein Kinase R-like Endoplasmic Reticulum Kinase-dependent Manner
J. Biol. Chem., April 6, 2007; 282(14): 10164 - 10171.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
N. Kobayashi, R. J. Barnard, S. M. Henning, D. Elashoff, S. T. Reddy, P. Cohen, P. Leung, J. Hong-Gonzalez, S. J. Freedland, J. Said, et al.
Effect of Altering Dietary {omega}-6/{omega}-3 Fatty Acid Ratios on Prostate Cancer Membrane Composition, Cyclooxygenase-2, and Prostaglandin E2
Clin. Cancer Res., August 1, 2006; 12(15): 4662 - 4670.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
R. Kaul, S. C. Verma, M. Murakami, K. Lan, T. Choudhuri, and E. S. Robertson
Epstein-Barr Virus Protein Can Upregulate Cyclo-Oxygenase-2 Expression through Association with the Suppressor of Metastasis Nm23-H1
J. Virol., February 1, 2006; 80(3): 1321 - 1331.
[Abstract] [Full Text] [PDF]

Home page
 Genome Res.Home page
J. N. Harada, K. E. Bower, A. P. Orth, S. Callaway, C. G. Nelson, C. Laris, J. B. Hogenesch, P. K. Vogt, and S. K. Chanda
Identification of novel mammalian growth regulatory factors by genome-scale quantitative image analysis
Genome Res., August 1, 2005; 15(8): 1136 - 1144.
[Abstract] [Full Text] [PDF]

Home page
 Ann. N. Y. Acad. Sci.Home page
C.-C. HOU, S.-L. HUNG, S.-H. KAO, T. H. CHEN, and H.-M. LEE
Celecoxib Induces Heme-Oxygenase Expression in Glomerular Mesangial Cells
Ann. N.Y. Acad. Sci., May 1, 2005; 1042(1): 235 - 245.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
L. W. Slice, T. Chiu, and E. Rozengurt
Angiotensin II and Epidermal Growth Factor Induce Cyclooxygenase-2 Expression in Intestinal Epithelial Cells through Small GTPases Using Distinct Signaling Pathways
J. Biol. Chem., January 14, 2005; 280(2): 1582 - 1593.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
W.-G. Deng, Y. Zhu, and K. K. Wu
Role of p300 and PCAF in regulating cyclooxygenase-2 promoter activation by inflammatory mediators
Blood, March 15, 2004; 103(6): 2135 - 2142.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
T. Wu, J. Leng, C. Han, and A. J. Demetris
The cyclooxygenase-2 inhibitor celecoxib blocks phosphorylation of Akt and induces apoptosis in human cholangiocarcinoma cells
Mol. Cancer Ther., March 1, 2004; 3(3): 299 - 307.
[Abstract] [Full Text]

Home page
 Cancer Res.Home page
C. Han, J. Leng, A. J. Demetris, and T. Wu
Cyclooxygenase-2 Promotes Human Cholangiocarcinoma Growth: Evidence for Cyclooxygenase-2-Independent Mechanism in Celecoxib-Mediated Induction of p21waf1/cip1 and p27kip1 and Cell Cycle Arrest
Cancer Res., February 15, 2004; 64(4): 1369 - 1376.
[Abstract] [Full Text] [PDF]

Home page
 FASEB J.Home page
R. PAI, T. NAKAMURA, W. S. MOON, and A. S. TARNAWSKI
Prostaglandins promote colon cancer cell invasion; signaling by cross-talk between two distinct growth factor receptors
FASEB J, September 1, 2003; 17(12): 1640 - 1647.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
Y. Pan, J.-S. Zhang, M. H. Gazi, and C. Y. F. Young
The Cyclooxygenase 2-specific Nonsteroidal Anti-inflammatory Drugs Celecoxib and Nimesulide Inhibit Androgen Receptor Activity via Induction of c-Jun in Prostate Cancer Cells
Cancer Epidemiol. Biomarkers Prev., August 1, 2003; 12(8): 769 - 774.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
F. G. Bottone Jr., J. M. Martinez, J. B. Collins, C. A. Afshari, and T. E. Eling
Gene Modulation by the Cyclooxygenase Inhibitor, Sulindac Sulfide, in Human Colorectal Carcinoma Cells: POSSIBLE LINK TO APOPTOSIS
J. Biol. Chem., July 3, 2003; 278(28): 25790 - 25801.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
D. Kamei, M. Murakami, Y. Nakatani, Y. Ishikawa, T. Ishii, and I. Kudo
Potential Role of Microsomal Prostaglandin E Synthase-1 in Tumorigenesis
J. Biol. Chem., May 23, 2003; 278(21): 19396 - 19405.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
L. Ermert, C. Dierkes, and M. Ermert
Immunohistochemical Expression of Cyclooxygenase Isoenzymes and Downstream Enzymes in Human Lung Tumors
Clin. Cancer Res., May 1, 2003; 9(5): 1604 - 1610.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
W.-C. Huang, J.-J. Chen, H. Inoue, and C.-C. Chen
Tyrosine Phosphorylation of I-{kappa}B Kinase {alpha}/{beta} by Protein Kinase C-Dependent c-Src Activation Is Involved in TNF-{alpha}-Induced Cyclooxygenase-2 Expression
J. Immunol., May 1, 2003; 170(9): 4767 - 4775.
[Abstract] [Full Text] [PDF]

Home page
 J. Dent. Res.Home page
T. E. Van Dyke and C.N. Serhan
Resolution of Inflammation: A New Paradigm for the Pathogenesis of Periodontal Diseases
J. Dent. Res., February 1, 2003; 82(2): 82 - 90.
[Abstract] [Full Text] [PDF]

Home page
 Crit. Rev. Oral Biol. Med.Home page
A. Kantarci and T. E. Van Dyke
LIPOXINSIN CHRONIC INFLAMMATION
Crit. Rev. Oral. Biol. Med., January 1, 2003; 14(1): 4 - 12.
[Abstract] [Full Text]

Home page
 Clin. Cancer Res.Home page
W.-G. Tong, X.-Z. Ding, R. Hennig, R. C. Witt, J. Standop, P. M. Pour, and T. E. Adrian
Leukotriene B4 Receptor Antagonist LY293111 Inhibits Proliferation and Induces Apoptosis in Human Pancreatic Cancer Cells
Clin. Cancer Res., October 1, 2002; 8(10): 3232 - 3242.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
W.-G. Tong, X.-Z. Ding, R. C. Witt, and T. E. Adrian
Lipoxygenase Inhibitors Attenuate Growth of Human Pancreatic Cancer Xenografts and Induce Apoptosis through the Mitochondrial Pathway
Mol. Cancer Ther., September 1, 2002; 1(11): 929 - 935.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
S. Arico, S. Pattingre, C. Bauvy, P. Gane, A. Barbat, P. Codogno, and E. Ogier-Denis
Celecoxib Induces Apoptosis by Inhibiting 3-Phosphoinositide-dependent Protein Kinase-1 Activity in the Human Colon Cancer HT-29 Cell Line
J. Biol. Chem., July 26, 2002; 277(31): 27613 - 27621.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
G. Hawcroft, M. D'Amico, C. Albanese, A. F. Markham, R. G. Pestell, and M. A. Hull
Indomethacin induces differential expression of {beta}-catenin, {gamma}-catenin and T-cell factor target genes in human colorectal cancer cells
Carcinogenesis, January 1, 2002; 23(1): 107 - 114.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Clin. Nutr.Home page
Q. Jiang, S. Christen, M. K Shigenaga, and B. N Ames
{gamma}-Tocopherol, the major form of vitamin E in the US diet, deserves more attention
Am. J. Clinical Nutrition, December 1, 2001; 74(6): 714 - 722.
[Abstract] [Full Text]

Home page
 Mol. Pharmacol.Home page
C.-C. Chen, K.-T. Chiu, S.-T. Chan, and J.-W. Chern
Conjugated Polyhydroxybenzene Derivatives Block Tumor Necrosis Factor-alpha -Mediated Nuclear Factor-kappa B Activation and Cyclooxygenase-2 Gene Transcription by Targeting Ikappa B Kinase Activity
Mol. Pharmacol., December 1, 2001; 60(6): 1439 - 1448.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
W. Thomas, Z. K. Ascott, D. Harmey, L. W. Slice, E. Rozengurt, and A. J. Lax
Cytotoxic Necrotizing Factor from Escherichia coli Induces RhoA-Dependent Expression of the Cyclooxygenase-2 Gene
Infect. Immun., November 1, 2001; 69(11): 6839 - 6845.
[Abstract] [Full Text] [PDF]

Home page
 FASEB J.Home page
M. ROMANO, A. CATALANO, M. NUTINI, E. D'URBANO, C. CRESCENZI, J. CLARIA, R. LIBNER, G. DAVI, and A. PROCOPIO
5-Lipoxygenase regulates malignant mesothelial cell survival: involvement of vascular endothelial growth factor
FASEB J, November 1, 2001; 15(13): 2326 - 2336.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
R. J. Bing, M. Miyataka, K. A. Rich, N. Hanson, X. Wang, H. D. Slosser, and S.-R. Shi
Nitric Oxide, Prostanoids, Cyclooxygenase, and Angiogenesis in Colon and Breast Cancer
Clin. Cancer Res., November 1, 2001; 7(11): 3385 - 3392.
[Abstract] [Full Text] [PDF]

Home page
 Cardiovasc ResHome page
R. J Bing
Myocardial ischemia and infarction: growth of ideas
Cardiovasc Res, July 1, 2001; 51(1): 13 - 20.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
J. Bigler, J. Whitton, J. W. Lampe, L. Fosdick, R. M. Bostick, and J. D. Potter
CYP2C9 and UGT1A6 Genotypes Modulate the Protective Effect of Aspirin on Colon Adenoma Risk
Cancer Res., May 1, 2001; 61(9): 3566 - 3569.
[Abstract] [Full Text]

Home page
 J. Exp. Med.Home page
C. N. Serhan, C. B. Clish, J. Brannon, S. P. Colgan, N. Chiang, and K. Gronert
Novel Functional Sets of Lipid-derived Mediators with Antiinflammatory Actions Generated from Omega-3 Fatty Acids via Cyclooxygenase 2-Nonsteroidal Antiinflammatory Drugs and Transcellular Processing
J. Exp. Med., October 16, 2000; 192(8): 1197 - 1204.
[Abstract] [Full Text] [PDF]

Home page
 ThoraxHome page
C. N Serhan and C. B Clish
Aspirin triggered lipid mediators: novel inhibitors of leucocyte trafficking
Thorax, October 1, 2000; 55(90002): 10S - 12.
[Full Text]

Home page
 Proc. Natl. Acad. Sci. USAHome page
Q. Jiang, I. Elson-Schwab, C. Courtemanche, and B. N. Ames
gamma -Tocopherol and its major metabolite, in contrast to alpha -tocopherol, inhibit cyclooxygenase activity in macrophages and epithelial cells
PNAS, September 22, 2000; (2000) 200357097.
[Abstract] [Full Text]

Home page
 ScienceHome page
M. G. Malkowski, S. L. Ginell, W. L. Smith, and R. M. Garavito
The Productive Conformation of Arachidonic Acid Bound to Prostaglandin Synthase
Science, September 15, 2000; 289(5486): 1933 - 1937.
[Abstract] [Full Text]

Home page
 Rheumatology (Oxford)Home page
F. A. Wollheim
Selective Cox-2 inhibition in man--therapeutic breakthrough or cosmetic advance?
Rheumatology, September 1, 2000; 39(9): 935 - 938.
[Full Text] [PDF]

Home page
 Cancer Res.Home page
Y. Huang, C. M. Horvath, and S. Waxman
Regrowth of 5-Fluorouracil-treated Human Colon Cancer Cells Is Prevented by the Combination of Interferon {{gamma}}, Indomethacin, and Phenylbutyrate
Cancer Res., June 1, 2000; 60(12): 3200 - 3206.
[Abstract] [Full Text]

Home page
 J. Pharmacol. Exp. Ther.Home page
E. Castaño, R. Bartrons, and J. Gil
Inhibition of Cyclooxygenase-2 Decreases DNA Synthesis Induced by Platelet-Derived Growth Factor in Swiss 3T3 Fibroblasts
J. Pharmacol. Exp. Ther., May 1, 2000; 293(2): 509 - 513.
[Abstract] [Full Text]

Home page
 Cancer Res.Home page
J. L. Masferrer, K. M. Leahy, A. T. Koki, B. S. Zweifel, S. L. Settle, B. M. Woerner, D. A. Edwards, A. G. Flickinger, R. J. Moore, and K. Seibert
Antiangiogenic and Antitumor Activities of Cyclooxygenase-2 Inhibitors
Cancer Res., March 1, 2000; 60(5): 1306 - 1311.
[Abstract] [Full Text]

Home page
 CarcinogenesisHome page
A. Papanikolaou, Q.-S. Wang, R. Mulherkar, A. Bolt, and D. W. Rosenberg
Expression analysis of the group IIA secretory phospholipase A2 in mice with differential susceptibility to azoxymethane-induced colon tumorigenesis
Carcinogenesis, February 1, 2000; 21(2): 133 - 138.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
C. N. SERHAN, T. TAKANO, N. CHIANG, K. GRONERT, and C. B. CLISH
Formation of Endogenous ""Antiinflammatory"" Lipid Mediators by Transcellular Biosynthesis . Lipoxins and Aspirin-triggered Lipoxins Inhibit Neutrophil Recruitment and Vascular Permeability
Am. J. Respir. Crit. Care Med., February 1, 2000; 161(2): S95 - 101.
[Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
K. S. Chapple, E. J. Cartwright, G. Hawcroft, A. Tisbury, C. Bonifer, N. Scott, A. C. J. Windsor, P. J. Guillou, A. F. Markham, P. L. Coletta, et al.
Localization of Cyclooxygenase-2 in Human Sporadic Colorectal Adenomas
Am. J. Pathol., February 1, 2000; 156(2): 545 - 553.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
D. Wolfle, S. Marotzki, D. Dartsch, W. Schafer, and H. Marquardt
Induction of cyclooxygenase expression and enhancement of malignant cell transformation by 2,3,7,8-tetrachlorodibenzo- p-dioxin
Carcinogenesis, January 1, 2000; 21(1): 15 - 21.
[Abstract] [Full Text] [PDF]

Home page
 Reproductive SciencesHome page
D. A. Kniss
Cyclooxygenases in Reproductive Medicine and Biology
Reproductive Sciences, November 1, 1999; 6(6): 285 - 292.
[Abstract] [PDF]

Home page
 Am. J. Physiol. Cell Physiol.Home page
E. Titos, N. Chiang, C. N. Serhan, M. Romano, J. Gaya, G. Pueyo, and J. Claria
Hepatocytes are a rich source of novel aspirin-triggered 15-epi-lipoxin A4
Am J Physiol Cell Physiol, November 1, 1999; 277(5): C870 - C877.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
A. von Knethen, D. Callsen, and B. Brune
Superoxide Attenuates Macrophage Apoptosis by NF-{kappa}B and AP-1 Activation That Promotes Cyclooxygenase-2 Expression
J. Immunol., September 1, 1999; 163(5): 2858 - 2866.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
J. Okami, H. Yamamoto, Y. Fujiwara, M. Tsujie, M. Kondo, S. Noura, S. Oshima, H. Nagano, K. Dono, K. Umeshita, et al.
Overexpression of Cyclooxygenase-2 in Carcinoma of the Pancreas
Clin. Cancer Res., August 1, 1999; 5(8): 2018 - 2024.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
R. Chinery, R. J. Coffey, R. Graves-Deal, S. C. Kirkland, S. C. Sanchez, W. E. Zackert, J. A. Oates, and J. D. Morrow
Prostaglandin J2 and 15-Deoxy-{{Delta}}12,14-prostaglandin J2 Induce Proliferation of Cyclooxygenase-depleted Colorectal Cancer Cells
Cancer Res., June 1, 1999; 59(11): 2739 - 2746.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
A. F. de Arriba, F. Cavalcanti, A. Miralles, Y. Bayón, A. Alonso, M. Merlos, J. García-Rafanell, and J. Forn
Inhibition of Cyclooxygenase-2 Expression by 4-Trifluoromethyl Derivatives of Salicylate, Triflusal, and Its Deacetylated Metabolite, 2-Hydroxy-4-trifluoromethylbenzoic Acid
Mol. Pharmacol., April 1, 1999; 55(4): 753 - 760.
[Abstract] [Full Text]

Home page
 Clin. Cancer Res.Home page
S. R. Ritland, J. A. Leighton, R. E. Hirsch, J. D. Morrow, A. L. Weaver, and S. J. Gendler
Evaluation of 5-Aminosalicylic Acid (5-ASA) for Cancer Chemoprevention: Lack of Efficacy against Nascent Adenomatous Polyps in the ApcMin Mouse
Clin. Cancer Res., April 1, 1999; 5(4): 855 - 863.
[Abstract] [Full Text] [PDF]

Home page
 Biol. Reprod.Home page
S.K. Das, J. Wang, S.K. Dey, and R.A. Mead
Spatiotemporal Expression of Cyclooxygenase 1 and Cyclooxygenase 2 during Delayed Implantation and the Periimplantation Period in the Western Spotted Skunk
Biol Reprod, April 1, 1999; 60(4): 893 - 899.
[Abstract] [Full Text]

Home page
 Mol. Biol. CellHome page
A. von Knethen, D. Callsen, and B. Brüne
NF-kappa B and AP-1 Activation by Nitric Oxide Attenuated Apoptotic Cell Death in RAW 264.7 Macrophages
Mol. Biol. Cell, February 1, 1999; 10(2): 361 - 372.
[Abstract] [Full Text]

Home page
 Ann. N. Y. Acad. Sci.Home page
J. L. MASFERRER, A. KOKI, and K. SEIBERT
COX-2 Inhibitors: A New Class of Antiangiogenic Agents
Ann. N.Y. Acad. Sci., January 1, 1999; 889(1): 84 - 86.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
K. C. Zimmermann, M. Sarbia, A.-A. Weber, F. Borchard, H. E. Gabbert, and K. Schror
Cyclooxygenase-2 Expression in Human Esophageal Carcinoma
Cancer Res., January 1, 1999; 59(1): 198 - 204.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
N. Chiang, T. Takano, C. B. Clish, N. A. Petasis, H.-H. Tai, and C. N. Serhan
Aspirin-Triggered 15-epi-Lipoxin A4 (ATL) Generation by Human Leukocytes and Murine Peritonitis Exudates: Development of a Specific 15-epi-LXA4 ELISA
J. Pharmacol. Exp. Ther., November 1, 1998; 287(2): 779 - 790.
[Abstract] [Full Text]

Home page
 JNCI J Natl Cancer InstHome page
M. M. Taketo
Cyclooxygenase-2 Inhibitors in Tumorigenesis (Part I)
J Natl Cancer Inst, October 21, 1998; 90(20): 1529 - 1536.
[Abstract] [PDF]

Home page
 J. Exp. Med.Home page
K. Gronert, A. Gewirtz, J. L. Madara, and C. N. Serhan
Identification of a Human Enterocyte Lipoxin A4 Receptor That Is Regulated by Interleukin (IL)-13 and Interferon gamma  and Inhibits Tumor Necrosis Factor alpha -induced IL-8 Release
J. Exp. Med., April 20, 1998; 187(8): 1285 - 1294.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
Q. Jiang, I. Elson-Schwab, C. Courtemanche, and B. N. Ames
gamma -Tocopherol and its major metabolite, in contrast to alpha -tocopherol, inhibit cyclooxygenase activity in macrophages and epithelial cells
PNAS, October 10, 2000; 97(21): 11494 - 11499.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1997 by The Federation of American Societies for Experimental Biology.